ZSCAN1 and neoplasm: found ZSCAN1 autoantibodies in the CSF of seven of nine patients with tumor-associated rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation and in 0/125 controls.